Generic Name: terbinafine topical
Applies to terbinafine topical: topical cream, topical gel/jelly, topical solution, topical spray
In addition to its needed effects, some unwanted effects may be caused by terbinafine topical (the active ingredient contained in Lamisil AT). In the event that any of these side effects do occur, they may require medical attention.
If any of the following side effects occur while taking terbinafine topical, check with your doctor or nurse as soon as possible:


Applies to terbinafine topical: topical cream, topical gel, topical solution, topical spray
Dermatologic side effects have included burning or irritation (1.3%), itching (1.1%), skin exfoliation (1%), and erythematous rash (0.9%).[Ref]
Therapy was discontinued in clinical trials by 0.2% of patients treated with terbinafine solution and 0.6% of patients treated with placebo.[Ref]
1. "Product Information. Lamisil (terbinafine)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ. 
Not all side effects for Lamisil AT may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Dryness
redness
 itching
burning
peeling 
rash
stinging
tingling
or other signs of skin irritation not present before use of this medicine

